MYO: Myomo Inc. Price to Sales

Symbol and logo of brand Myomo Inc. (MYO)

Myomo, Inc. (MYO) automates the configuration of exoskeleton sensors, reducing routine tasks for physicians, although the production of physical devices requires capital expenditure. The historical P/S trend on the GURU.Markets dynamic chart, where the parameter value equals 1.10, reconciles these aspects. High margins are sustained by the uniqueness of MyoPro, while the primary growth driver will be the recognition of the equipment by government insurance programs.

MYO (Myomo) P/S Multiple history from 07/04/2022 to 11/13/2026

Analytical breakdowns for Myomo, Inc (MYO)

- market price and analyst price targets:
- market capitalization information:
Fundamental company analysis:myomo.com MYO
Original product of Myomo, Inc

A steady cash flow from insurance reimbursements for Myomo, Inc. (MYO) prosthetics has normalized the business's liquidity. The P/S metric compares the company's market capitalization with its annual revenue, excluding the impact of net income. It is critical for investors to determine whether the asset is overvalued relative to actual sales. The trend of these proportions on the P/S ratio chart allows for the timely identification of overpayment risks or stock undervaluation.

Who Myomo, Inc. competes with

Market Cap to Revenue bostonscientific.com BSX|P/S Multiple EW (Edwards Lifesciences Corporation)|ResMed Inc (RMD) - Price to Sales|OmniPod - P/S Multiple|ZBH (Zimmer Biomet Holdings) - Market Cap to Revenue Ratio|COO: P/S Multiple|ALGN - Price-to-Revenue Coefficient|GMED (Globus Medical) - P/S Multiple|Market Cap to Revenue TransMedics Group Inc (TMDX)|P/S Multiple ATEC|P/S Multiple Artivion Corp (AORT)|Price-to-Revenue Ratio Enovis Corporation ENOV|integralife.com - Price-to-Revenue Ratio|ESTA: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio BBNX (Beta Bionics, Inc.)|IRMD: P/S Multiple|Price to Sales Embecta Health (EMBC)|Price-to-Revenue Ratio Tandem Diabetes Care|AXGN - Price-to-Revenue Multiple|Market Cap to Revenue SIBN (SI-BONE)|P/S Multiple Orthofix Medical (OFIX)|P/S Multiple BVS (Bioventus Corp)|Price-to-Revenue Coefficient OrthoPediatrics Corp (KIDS)|TMCI - Price-to-Revenue Ratio|Price-to-Sales Ratio SRTA|Carlsmed (CARL) - Price-to-Revenue Ratio|Market Cap to Revenue RxSight Inc|CLPT (ClearPoint Neuro Inc.) - P/S Multiple|Price to Sales Stereotaxis Corporation STXS|Price-to-Revenue Ratio Neuronetics, Inc. (STIM)|sightsciences.com - Market Cap to Revenue Ratio|Orchestra BioMed, Inc. - Market Cap to Revenue|Market Cap to Sales Volume ANIK (Anika Therapeutics Inc.)|NSPR - Price-to-Revenue Ratio|Jin Medical International (ZJYL) - Market Cap to Revenue|VANI (vivani.com) - Market Cap to Revenue|Price to Sales Xtant Medical (XTNT)|Price-to-Revenue Ratio NeuroOne Medical Technologies Corporation|Price to Sales Modular Med MODD|Price-to-Revenue Ratio Envoy Medical, Inc (COCH)|Market Cap to Revenue Vivos Therapeutics Inc VVOS|Price-to-Revenue Ratio enVVeno Medical NVNO|Sintx Technologies Inc (SINT) - Price to Sales|TNON: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio LFWD (ReWalk Robotics)|AMIX: P/S Multiple|IVF - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Bone Biologics|Market Cap to Revenue Ratio AXNX (axonics.com)|P/S Multiple BIOL|Market Cap to Revenue dynatronics.com DYNT|Paragon 28 - Market Cap to Revenue|Price-to-Revenue Coefficient INVO Bioscience Inc. (INVO)